CAMBRYN BIOLOGICS ANNOUNCES STRATEGIC ADVISORY BOARD
SARASOTA, Florida – July 16, 2013, Mark P. Famiglio, CEO of Cambryn Biologics, a privately held Delaware corporation, announces the launch of its Strategic Advisory Board. “Cambryn is privileged to be working with its Strategic Advisory Board, composed of established international leaders in the pharmaceutical/biotech industry,” said Famiglio.

CAMBRYN BIOLOGICS ANNOUNCES KEY HIRINGS OF TWO SENIOR DIRECTORS
SARASOTA, Florida – May, 2013, Mark P. Famiglio, CEO of Cambryn Biologics, a privately held Delaware corporation, announces key hirings of two senior directors.

Cambryn Biologics LLC

Cambryn Biologics LLC is a Delaware corporation having its principal facility and offices in Sarasota, Florida. Cambryn is an emerging biotherapeutic company dedicated to the development, manufacturing and commercialization of biologic products for the management and treatment of clotting factor deficiencies.

logo small

State-of-the-Art Manufacturing Facility

Our facility consists of 50,000 square feet, located adjacent to the Sarasota/Bradenton International Airport, Sarasota, Florida, USA. Cambryn Biologics operates a state-of-the-art manufacturing facility.

Contact Details

Address: 600 Tallevast Rd.
Suite 201 Sarasota, FL 34243

Phone: (941) 355-7400

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.